Pertussis vaccination and the risk of respiratory syncytial virus-associated hospitalization

被引:3
|
作者
Boyce, TG [1 ]
Weaver, AL
St Sauver, JL
Woodward-Lee, AE
Stancl, JK
Park, JY
Jacobsen, SJ
Jacobson, RM
Poland, GA
机构
[1] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Biostat, Rochester, MN USA
[3] Mayo Clin, Dept Epidemiol, Rochester, MN USA
[4] Mayo Clin, Dept Internal Med, Rochester, MN USA
[5] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN USA
[6] Mayo Clin, Clin Res Training Program, Rochester, MN USA
关键词
pertussis; diphtheria-tetanus-acellular pertussis vaccine; vaccine; immunization; respiratory syncytial virus;
D O I
10.1097/01.inf.0000141725.45280.6c
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Animal data suggest an association between recent vaccination with a pertussis-containing vaccine and increased severity of respiratory syncytial virus (RSV) infection. We sought to determine whether such an association exists in humans by studying a population-based cohort of young children. Patients and Methods: We performed a nested case-control study of 280 children younger than 24 months of age hospitalized with RSV infection in Olmsted County, MN from January 1990 to December 1999. Controls (2 per case) consisted of nonhospitalized residents of Olmsted County matched to cases by date of birth and sex. Odds ratios (OR) and 95% confidence intervals (CI) were calculated for the odds of hospitalization for RSV infection among subjects with a recent pertussis-containing vaccination in proximity to the cases' date of hospitalization relative to the odds among subjects with no vaccination. Results: The OR for receipt of a pertussis-containing vaccine within 0 to 6 days of a case's hospitalization for RSV disease was 0.8 (95% CI 0.4-1.8). For the time intervals 7-13, 14-20 and greater than or equal to21 days, the OR were 1.3 (95% CI 0.5-3.0), 1.3 (95% CI 0.5-3.2) and 0.7 (95% CI 0.3-1.5), respectively. Adjusting for vaccine delay and for risk status did not alter the findings. The median interval between the most recent pertussis-containing vaccine and the case's date of hospitalization was 40 days for cases and 42.5 days for controls (P = 0.69). Among the RSV cases, pertussis vaccination in the month preceding hospitalization was not a risk factor for oxygen requirement (P = 0.82), intensive care unit admission (P = 0.46) or need for mechanical ventilation (P = 0.28). Conclusion: In our study, recent immunization with a pertussis-containing vaccine was not a risk factor for hospitalization for RSV infection. In addition, among children hospitalized with RSV infection, recent pertussis immunization was not associated with a more severe clinical course.
引用
收藏
页码:897 / 901
页数:5
相关论文
共 50 条
  • [1] Severity of illness models for respiratory syncytial virus-associated hospitalization
    Moler, FW
    Ohmit, SE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (04) : 1234 - 1240
  • [2] Respiratory syncytial virus-associated hospitalization rates in high-risk populations: an observational comparative cohort analysis
    Resch, B.
    Puchas, C.
    Urlesberger, B.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (12) : 2413 - 2414
  • [3] Respiratory syncytial virus-associated hospitalization rates in high-risk populations: an observational comparative cohort analysis
    B. Resch
    C. Puchas
    B. Urlesberger
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 2413 - 2414
  • [4] Respiratory Syncytial Virus-Associated Hepatitis in Pregnancy
    Malik, Alexander
    Yousaf, Muhammad Nadeem
    Abdelnour, John
    Samiullah, Sami
    Veysel, Tahan
    Mahdi, Amin
    Basar, Omer
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S2025 - S2026
  • [5] Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact
    Sorup, Signe
    Benn, Christine Stabell
    Stensballe, Lone Graff
    Aaby, Peter
    Ravn, Henrik
    VACCINE, 2015, 33 (01) : 237 - 245
  • [6] Respiratory Syncytial Virus-Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study
    Osei-Yeboah, Richard
    Johannesen, Caroline Klint
    Egeskov-Cavling, Amanda Marie
    Chen, Junru
    Lehtonen, Toni
    Fornes, Arantxa Urchueguia
    Paget, John
    Fischer, Thea K.
    Wang, Xin
    Nair, Harish
    Campbell, Harry
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 : S70 - S77
  • [7] Respiratory Syncytial Virus-Associated Respiratory Diseases in Children and Adults
    Tenenbaum, Tobias
    Liese, Johannes
    Welte, Tobias
    Rademacher, Jessica
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2024, 121 (09): : 303 - 312
  • [8] Risk Factors for Respiratory Syncytial Virus-Associated Community Deaths in Zambian Infants
    Murphy, Caitriona
    MacLeod, William B.
    Forman, Leah S.
    Mwananyanda, Lawrence
    Kwenda, Geoffrey
    Pieciak, Rachel C.
    Mupila, Zachariah
    Thea, Donald
    Chikoti, Chilufya
    Yankonde, Baron
    Ngoma, Bernard
    Chimoga, Charles
    Gill, Christopher J.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 : S187 - S192
  • [9] RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED BRONCHOPNEUMONIA IN A YOUNG CHIMPANZEE
    CLARKE, CJ
    WATT, NJ
    MEREDITH, A
    MCINTYRE, N
    BURNS, SM
    JOURNAL OF COMPARATIVE PATHOLOGY, 1994, 110 (02) : 207 - 212
  • [10] Risk factors for severe respiratory syncytial virus-associated lower respiratory tract infection in children
    Kaneko, M
    Watanabe, J
    Ueno, E
    Hida, M
    Sone, T
    PEDIATRICS INTERNATIONAL, 2001, 43 (05) : 489 - 492